Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.
Informed written consent will be taken from all subjects included in the study after approval of the study by the local ethical committee.
All subjects will be subjected to thorough history taking with risk factors, medical histories, general clinical examination, local clinical examination, laboratory investigations as complete blood count and coagulation profile.
Standardized anesthetic care will be provided according to institutional standards, which include fasting, antacid premedication and noninvasive hemodynamic monitoring After arrival in the operating room, patients will be positioned supine with left lateral tilt, pulse oximeter, ECG leads, non-invasive blood pressure cuff and cardiometry leads (4 surface ECG electrodes is attached to the left side of the neck and the lower thorax (approximately at the level of the xiphoid process) will be attached to patient for monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance and values will be recorded as a baseline and every 10 minutes after intrathecal injection.
10 ml/kg/hr lactated ringer solution will be infused to all patients through an 18 gauge intravenous cannula for 30 minutes as a preload before spinal anesthesia then reduced to maintenance infusion of 6 ml/kg/hr.
Patients will be then placed in sitting position. After skin disinfection and skin infiltration with lidocaine 1%, spinal anesthesia will be performed with 2ml 0.5% hyperbaric bupivacaine (10 mg) in addition to 0.5 ml fentanyl (25 μg) at L3-L4 or L4-L5.
The patient will be then returned to the left-tilted supine position. The study drug regimen will be started immediately after intrathecal injection.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| infusion | Active Comparator | patients will receive an infusion of norepinephrine that will be started at 2.5μg/min immediately after intrathecal injection and then manually adjusted according to monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance by using cardiometry, with the objective of maintaining values near baseline |
|
| bolus | Active Comparator | patient with no prophylactic vasopressor and a bolus of 5 μg norepinephrine will be given whenever systolic BP decreases to <80% of the baseline value. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Norepinephrine bolus | Drug | 5 microgram bolus therapy |
| |
| cardiometry |
| Measure | Description | Time Frame |
|---|---|---|
| throracic volume variations change from baseline | using cardiometry | every 10 minutes up to 1 hour |
| cardiac index change from baseline | using cardiometry | every 10 minutes up to 1 hour |
| systemic vascular resistance change from baseline | using cardiometry | every 10 minutes up to 1 hour |
| stroke volume variation change from baseline | using cardiometry | every 10 minutes and up to 1 hour |
| Measure | Description | Time Frame |
|---|---|---|
| umblical cord gases sample | in the first minute after delivery | |
| APGAR score | score from 1 to 10 with the highest score better for neonatal outcome | after 5 minutes and 10 minutes after delivery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
pregnant females
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Faculty of Medicine, University Hospitals | Shibīn al Kawm | Menoufia | 32511 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007022 | Hypotension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
cardiac output, stroke volume and fluid responsiveness monitoring |
|
| Norepinephrine infusion | Drug | 2.5 microgram/min infusion |
|
| Non invasive MEAN blood pressure | change from baseline | every 10 minutes and up tp 1 hour |
| Heart rate | change from baseline | every 10 minutes and up to 1 hour |